Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Trial record 1 of 1 for:    BTTC 11-01
Previous Study | Return to List | Next Study

Lacosamide for Seizure Prophylaxis in High-Grade Gliomas

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2014 by M.D. Anderson Cancer Center
Sponsor:
Collaborators:
Brain Tumor Trials Collaborative
UCB Pharma
Information provided by (Responsible Party):
M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier:
NCT01432171
First received: September 8, 2011
Last updated: November 17, 2014
Last verified: November 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: July 2018 (Final data collection date for primary outcome measure)